1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. SLC39 (Zinc Transporter)
  4. SLC39 (Zinc Transporter) Inhibitor

SLC39 (Zinc Transporter) Inhibitor

SLC39 (Zinc Transporter) Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P991145
    Laventatug
    Inhibitor
    Laventatug is a humanized monoclonal antibody targeting human SLC39A6. Laventatug specifically binds to SLC39A6, interfering with the intracellular zinc ion transport process and thus exerting antitumor activity. Laventatug is promising for research of cancers.